Table 2:
Variable | Psoriasis (n=47) | Controls (n=159) (Rosacea + Atopic Dermatitis) |
P-value |
---|---|---|---|
Total Positive LGE | 23 (50%) | 45 (29%) | 0.0122 |
ECV Septal (%) Recentered (25) | 4 ± 7.34 | 0.365 ± 5.07 | 0.02 |
ECV Lateral (%) Recentered (25) | 1.14 ± 6.14 | −0.47 ± 5.3 | 0.14 |
Abnormal T2 septal (normal: 52.18 ± 3.4) | 18 (60%) | 28 (34%) | 0.0168 |
Abnormal T2 lateral (normal: 52.18 ± 3.4) | 14 (48%) | 45 (54%) | 0.6675 |
Abnormal EF (<55%) | 14 (30%) | 33 (21%) | 0.2355 |
Abnormal MRI (any finding) | 34 (72%) | 86 (54%) | 0.0291 |
Hematocrit reported for normalization of extracellular fracture volume. Late gadolinium enhancement differences were not detected in terms of absolute occurrence or by coronary artery distribution. Continuous variables analyzed by t-testing and values represent mean ± standard deviation, categorical variables by χ2 testing.